Skip to main content
Erschienen in: Supportive Care in Cancer 11/2015

01.11.2015 | Original Article

Potential factors associated with perceived cognitive impairment in breast cancer survivors

verfasst von: Jamie S. Myers, Jo A. Wick, Jennifer Klemp

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This cross-sectional study was designed to explore potential factors associated with perceived cognitive impairment (PCI) in breast cancer survivors compared to controls and gain insight into perceived levels of severity for cognitive complaints.

Methods

Women (N = 363, 317: breast cancer, 46: healthy controls) completed demographic questionnaire, MD Anderson Symptom Inventory, Attentional Function Index, and Functional Assessment for Cancer Therapy-Cognition. Group classification included pre-chemotherapy, current chemotherapy, and postchemotherapy (<1, >1– < 2, >2– < 5, >5 years).

Results

A significant group effect was seen for PCI (F 6, 355 = 7.01, p < 0.0001). Controls reported less PCI than all other groups. Neuropathy was inversely correlated with PCI (r = −0.23; p < 0.0001) for participants with breast cancer. A significant association was demonstrated between exercise frequency and PCI in women exposed to chemotherapy (F 3, 135 = 3.78, p < 0.05). A multiple linear regression model built using forward selection methods explained 24 % of the variance (adjusted R 2) for PCI in breast cancer participants and included group, body mass index (BMI), exercise, fatigue, and distress. Exercise frequency moderated the relationship between BMI and PCI for breast cancer participants (F 3, 198 = 2.4, p = 0.07) and reduced the negative effects of high BMI. The moderating effect of exercise was significant (F 3, 133 = 3.1, p = 0.03) when limited to participants exposed to chemotherapy.

Conclusions

PCI decreased for women >5 years postchemotherapy. Overweight survivors who exercised frequently reported less PCI than sedentary survivors. Study results provide support for a relationship between BMI and PCI in breast cancer survivors and exercise as a potential intervention for cognitive complaints. Further investigation of the influence of weight and exercise on cognitive function is warranted.
Literatur
2.
Zurück zum Zitat Collins B, MacKenzie J, Tasca GA, Scherling C, Smith AD (2013) Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psychooncology 7:1517–1527. doi:10.1002/pon.3163 Collins B, MacKenzie J, Tasca GA, Scherling C, Smith AD (2013) Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psychooncology 7:1517–1527. doi:10.​1002/​pon.​3163
4.
Zurück zum Zitat Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB (2012) Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 30:1080–1086CrossRefPubMed Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB (2012) Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 30:1080–1086CrossRefPubMed
5.
Zurück zum Zitat Hess LM, Insel KC (2007) Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum 24:981–994CrossRef Hess LM, Insel KC (2007) Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum 24:981–994CrossRef
7.
Zurück zum Zitat Jansen C, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 32:1151–1163CrossRefPubMed Jansen C, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 32:1151–1163CrossRefPubMed
8.
Zurück zum Zitat Dietrich J, Han R, Yang Y, Mayer-Proschel M, Noble M (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5:1–23CrossRef Dietrich J, Han R, Yang Y, Mayer-Proschel M, Noble M (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5:1–23CrossRef
9.
Zurück zum Zitat Cleeland CS, Bennett G, Dantzer R, Dougherty PM, Dunn AJ, Meyers C, Miller AH, Payne R, Reuben JM, Wang XS, Lee BN (2003) Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97:2919–2925CrossRefPubMed Cleeland CS, Bennett G, Dantzer R, Dougherty PM, Dunn AJ, Meyers C, Miller AH, Payne R, Reuben JM, Wang XS, Lee BN (2003) Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97:2919–2925CrossRefPubMed
10.
Zurück zum Zitat Cimprich B, So H, Ronis DL, Trask C (2005) Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 14:70–78CrossRefPubMed Cimprich B, So H, Ronis DL, Trask C (2005) Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 14:70–78CrossRefPubMed
11.
Zurück zum Zitat Myers JS, Sousa VD, Donovan HS (2010) Predictors of self-reported memory problems in patients with ovarian cancer who have received chemotherapy. Oncol Nurs Forum 37:596–603CrossRefPubMed Myers JS, Sousa VD, Donovan HS (2010) Predictors of self-reported memory problems in patients with ovarian cancer who have received chemotherapy. Oncol Nurs Forum 37:596–603CrossRefPubMed
12.
Zurück zum Zitat Erion JR, Wosiski-Kuhn M, Dey A, Hao S, Davis CL, Pollock NK, Stranahan AM (2014) Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity. J Neurosci 34:2618–2631PubMedCentralCrossRefPubMed Erion JR, Wosiski-Kuhn M, Dey A, Hao S, Davis CL, Pollock NK, Stranahan AM (2014) Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity. J Neurosci 34:2618–2631PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Stranahan AM, Mattson MP (2012) Recruiting adaptive cellular stress responses for successful brain aging. Nat Rev Neurosci 13:209–216PubMedCentralPubMed Stranahan AM, Mattson MP (2012) Recruiting adaptive cellular stress responses for successful brain aging. Nat Rev Neurosci 13:209–216PubMedCentralPubMed
14.
Zurück zum Zitat da Cunha PA, de Carlos Back LK, Sereia AF, Kubelka C, Ribeiro MC, Fernandes BL, de Souza IR (2013) Interaction between obesity-related genes, FTO and MC4R, associated to an increase of breast cancer risk. Mol Biol Rep 40:6657–6664CrossRefPubMed da Cunha PA, de Carlos Back LK, Sereia AF, Kubelka C, Ribeiro MC, Fernandes BL, de Souza IR (2013) Interaction between obesity-related genes, FTO and MC4R, associated to an increase of breast cancer risk. Mol Biol Rep 40:6657–6664CrossRefPubMed
15.
Zurück zum Zitat Dalamaga M (2013) Obesity, insulin resistance, adipocytokines and breast cancer: new biomarkers and attractive therapeutic targets. World J Exp Med 3(3):34–42PubMedCentralPubMed Dalamaga M (2013) Obesity, insulin resistance, adipocytokines and breast cancer: new biomarkers and attractive therapeutic targets. World J Exp Med 3(3):34–42PubMedCentralPubMed
16.
Zurück zum Zitat Lankester KJ, Phillips E, Lawton PA (2002) Weight gain during adjuvant and neoadjuvant chemotherapy for breast cancer: an audit of 100 women receiving FEC or CMF chemotherapy. Clin Oncol (R Coll Radiol) 14:64–67CrossRef Lankester KJ, Phillips E, Lawton PA (2002) Weight gain during adjuvant and neoadjuvant chemotherapy for breast cancer: an audit of 100 women receiving FEC or CMF chemotherapy. Clin Oncol (R Coll Radiol) 14:64–67CrossRef
17.
Zurück zum Zitat Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, Faerber S, Pierce J (1999) Factors associated with weight gain in women after diagnosis of breast cancer. J Am Diet Assoc 99:1212–1221CrossRefPubMed Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, Faerber S, Pierce J (1999) Factors associated with weight gain in women after diagnosis of breast cancer. J Am Diet Assoc 99:1212–1221CrossRefPubMed
18.
Zurück zum Zitat Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AG (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. J Am Med Assoc 292:2237–2242CrossRef Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AG (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. J Am Med Assoc 292:2237–2242CrossRef
19.
Zurück zum Zitat Colcombe SJ, Erickson KI, Scalf PE, Kim JS, Prakash R, McAuley E, Elavsky S, Marquez DX, Hu L, Kramer AF (2006) Aerobic exercise training increases brain volume in aging humans. J Gerontol A: Biol Med Sci 61(11):1166–1170CrossRef Colcombe SJ, Erickson KI, Scalf PE, Kim JS, Prakash R, McAuley E, Elavsky S, Marquez DX, Hu L, Kramer AF (2006) Aerobic exercise training increases brain volume in aging humans. J Gerontol A: Biol Med Sci 61(11):1166–1170CrossRef
20.
Zurück zum Zitat Colcombe SJ, Kramer AF (2003) Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 14:125–130CrossRefPubMed Colcombe SJ, Kramer AF (2003) Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 14:125–130CrossRefPubMed
21.
Zurück zum Zitat Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F (2004) Physical activity, including walking, and cognitive function in older women. J Am Med Assoc 292(12):1454–1461CrossRef Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F (2004) Physical activity, including walking, and cognitive function in older women. J Am Med Assoc 292(12):1454–1461CrossRef
22.
Zurück zum Zitat de Andrade L, Gobbi L, Coelho F, Christofoletti G, Costa JL, Stella F (2013) Benefits of multimodal exercise intervention for postural control and frontal cognitive functions in individuals with Alzheimer's disease: a controlled trial. J Am Geriatr Soc 61:1919–1926CrossRefPubMed de Andrade L, Gobbi L, Coelho F, Christofoletti G, Costa JL, Stella F (2013) Benefits of multimodal exercise intervention for postural control and frontal cognitive functions in individuals with Alzheimer's disease: a controlled trial. J Am Geriatr Soc 61:1919–1926CrossRefPubMed
23.
Zurück zum Zitat Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K (2001) Physical activity and risk of cognitive impairment and dementia in elderly persons. J Am Med Assoc 58:498–504 Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K (2001) Physical activity and risk of cognitive impairment and dementia in elderly persons. J Am Med Assoc 58:498–504
24.
Zurück zum Zitat Vidoni ED, Van Sciver A, Johnson DK, He J, Honea R, Haines B, Goodwin J, Laubinger MP, Anderson HS, Kluding PM, Donnelly JE, Billinger SA, Burns JM (2012) A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease. Contemp Clin Trials 33:1105–1116PubMedCentralCrossRefPubMed Vidoni ED, Van Sciver A, Johnson DK, He J, Honea R, Haines B, Goodwin J, Laubinger MP, Anderson HS, Kluding PM, Donnelly JE, Billinger SA, Burns JM (2012) A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease. Contemp Clin Trials 33:1105–1116PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Baumann FT, Drosselmeyer N, Leskaroski A, Knicker A, Krakowski-Roosen H, Zopf EM, Bloch W (2011) 12-Week resistance training with breast cancer patients during chemotherapy: effects on cognitive abilities. Breast Care 6:142–143CrossRef Baumann FT, Drosselmeyer N, Leskaroski A, Knicker A, Krakowski-Roosen H, Zopf EM, Bloch W (2011) 12-Week resistance training with breast cancer patients during chemotherapy: effects on cognitive abilities. Breast Care 6:142–143CrossRef
26.
Zurück zum Zitat Fardell JE, Vardy J, Winocur G (2011) Chemotherapy and cognitive impairment: treatment options. Nature 90:366–376 Fardell JE, Vardy J, Winocur G (2011) Chemotherapy and cognitive impairment: treatment options. Nature 90:366–376
27.
Zurück zum Zitat Galantino ML, Greene L, Daniels L, Dooley B, Muscatello L, O'Donnell L (2012) Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series. Explore 8:127–135CrossRefPubMed Galantino ML, Greene L, Daniels L, Dooley B, Muscatello L, O'Donnell L (2012) Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series. Explore 8:127–135CrossRefPubMed
28.
Zurück zum Zitat Korstjens I, Mesters I, van der Peet E, Gijsen B, van den Borne B (2006) Quality of life of cancer survivors after physical and psychosocial rehabilitation. Eur J Cancer Prev 15:541–547CrossRefPubMed Korstjens I, Mesters I, van der Peet E, Gijsen B, van den Borne B (2006) Quality of life of cancer survivors after physical and psychosocial rehabilitation. Eur J Cancer Prev 15:541–547CrossRefPubMed
29.
Zurück zum Zitat Oh B, Butow PN, Mullan BA, Clarke SJ, Beale PJ, Pavlakis N, Lee MS, Rosenthal DS, Larkey L, Vardy J (2012) Effect of medical qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Support Care Cancer 20:1235–1242. doi:10.1007/s00520-011-1209-6 CrossRefPubMed Oh B, Butow PN, Mullan BA, Clarke SJ, Beale PJ, Pavlakis N, Lee MS, Rosenthal DS, Larkey L, Vardy J (2012) Effect of medical qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Support Care Cancer 20:1235–1242. doi:10.​1007/​s00520-011-1209-6 CrossRefPubMed
30.
Zurück zum Zitat Reid-Arndt AA, Matsuda S, Cox CR (2012) Tai chi effects on neuropsychological, emotional, and physical functioning following cancer treatment: a pilot study. Complement Ther Clin Pract 18:26–30CrossRefPubMed Reid-Arndt AA, Matsuda S, Cox CR (2012) Tai chi effects on neuropsychological, emotional, and physical functioning following cancer treatment: a pilot study. Complement Ther Clin Pract 18:26–30CrossRefPubMed
31.
Zurück zum Zitat Sprod LK, Mohile SG, Demark-Wahnefried W, Janelsins MC, Peppone LJ, Morrow GR, Lord R, Gross H, Mustian KM (2012) Exercise and cancer treatment symptoms in 408 newly diagnosed older cancer patients. J Geriatr Oncol 3:90–97PubMedCentralCrossRefPubMed Sprod LK, Mohile SG, Demark-Wahnefried W, Janelsins MC, Peppone LJ, Morrow GR, Lord R, Gross H, Mustian KM (2012) Exercise and cancer treatment symptoms in 408 newly diagnosed older cancer patients. J Geriatr Oncol 3:90–97PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Crowgey T, Peters KB, Hornsby WE, Lane A, McSherry F, Herndon JE, West MJ, Williams CL, Jones LW (2014) Relationship between exercise behavior, cardiorespiratory fitness, and cognitive function in early breast cancer patients treated with doxoubicin-containing chemotherapy: a pilot study. Appl Physiol Nutr Metab 39:724–729PubMedCentralCrossRefPubMed Crowgey T, Peters KB, Hornsby WE, Lane A, McSherry F, Herndon JE, West MJ, Williams CL, Jones LW (2014) Relationship between exercise behavior, cardiorespiratory fitness, and cognitive function in early breast cancer patients treated with doxoubicin-containing chemotherapy: a pilot study. Appl Physiol Nutr Metab 39:724–729PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney KH, Morgan MA, Moslehi JJ, O'Conner T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriquez MA, Syrjala KL, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA (2014) Survivorship: healthy lifestyles, version 2.2014. J Natl Compr Cancer Netw 12:1222–1237 Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahefried W, Dizon D, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney KH, Morgan MA, Moslehi JJ, O'Conner T, Overholser L, Paskett ED, Peppercorn J, Raza M, Rodriquez MA, Syrjala KL, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA (2014) Survivorship: healthy lifestyles, version 2.2014. J Natl Compr Cancer Netw 12:1222–1237
34.
Zurück zum Zitat Ahles TA, Saykin AJ (2001) Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investig 19:812–820CrossRef Ahles TA, Saykin AJ (2001) Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investig 19:812–820CrossRef
35.
Zurück zum Zitat Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422–430CrossRefPubMed Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15:422–430CrossRefPubMed
36.
Zurück zum Zitat Merriman JD, Jansen C, Koetters T, West C, Dodd M, Lee K, Paul SM, Aouizerat BE, Cooper B, Swift PS, Wara W, Miaskowski C (2010) Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy. Oncol Nurs Forum 37:423–432PubMedCentralCrossRefPubMed Merriman JD, Jansen C, Koetters T, West C, Dodd M, Lee K, Paul SM, Aouizerat BE, Cooper B, Swift PS, Wara W, Miaskowski C (2010) Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy. Oncol Nurs Forum 37:423–432PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M.D. Anderson symptom inventory. Cancer 89:1634–1646CrossRefPubMed Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M.D. Anderson symptom inventory. Cancer 89:1634–1646CrossRefPubMed
38.
Zurück zum Zitat Wagner L, Sweet J, Butt Z, Lai J, Cella D (2009) Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol 7:W32–W39 Wagner L, Sweet J, Butt Z, Lai J, Cella D (2009) Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol 7:W32–W39
39.
Zurück zum Zitat Cimprich B, Visovatti M, Ronis DL (2011) The attentional function index- A self-report cognitive measure. Psychooncology 20:194–202CrossRefPubMed Cimprich B, Visovatti M, Ronis DL (2011) The attentional function index- A self-report cognitive measure. Psychooncology 20:194–202CrossRefPubMed
40.
Zurück zum Zitat Ahles TA, Saykin A (2002) Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 3(Suppl 3):S84–S90CrossRefPubMed Ahles TA, Saykin A (2002) Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 3(Suppl 3):S84–S90CrossRefPubMed
41.
Zurück zum Zitat Sanford SD, Beaumont JL, Butt Z, Sweet J, Cella D, Wagner L (2014) Prospecrive longitudinal evaluation of a symptom cluster in breast cancer. J Pain Symptom Manag 47:721–730CrossRef Sanford SD, Beaumont JL, Butt Z, Sweet J, Cella D, Wagner L (2014) Prospecrive longitudinal evaluation of a symptom cluster in breast cancer. J Pain Symptom Manag 47:721–730CrossRef
42.
Zurück zum Zitat Lai J, Wagner L, Jacobsen PB, Cella D (2014) Self-reported cognitive concerns and abilities: two sides of one coin? Psychooncology. doi:10.1002/pon.3522 Lai J, Wagner L, Jacobsen PB, Cella D (2014) Self-reported cognitive concerns and abilities: two sides of one coin? Psychooncology. doi:10.​1002/​pon.​3522
43.
Zurück zum Zitat Kirk-Sanchez NJ, McGough EL (2014) Physical exercise and cognitive performance in the elderly: current perspectives. Clin Interv Aging 9:51–62PubMedCentralPubMed Kirk-Sanchez NJ, McGough EL (2014) Physical exercise and cognitive performance in the elderly: current perspectives. Clin Interv Aging 9:51–62PubMedCentralPubMed
44.
Zurück zum Zitat Schwartz CE (2010) Applications of response shift theory and methods to participation measurement: a brief history of a young field. Arch Phys Med Rehabil 91(Suppl 1):S38–S43CrossRefPubMed Schwartz CE (2010) Applications of response shift theory and methods to participation measurement: a brief history of a young field. Arch Phys Med Rehabil 91(Suppl 1):S38–S43CrossRefPubMed
45.
Zurück zum Zitat Jansen CE, Miaskowski CA, Dodd MJ, Dowling GA (2007) A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncol Nurs Forum 34:997–1005CrossRefPubMed Jansen CE, Miaskowski CA, Dodd MJ, Dowling GA (2007) A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncol Nurs Forum 34:997–1005CrossRefPubMed
46.
Zurück zum Zitat Saykin A, Wishart HA, Rabin LA, Santulli RB, Flashman LA, West JD, McHugh TL, Mamourian AC (2006) Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 67:834–842PubMedCentralCrossRefPubMed Saykin A, Wishart HA, Rabin LA, Santulli RB, Flashman LA, West JD, McHugh TL, Mamourian AC (2006) Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 67:834–842PubMedCentralCrossRefPubMed
47.
Zurück zum Zitat Stommel M, Schoenborn CA (2009) Accuracy and usefulness of BMI measures based on self-reported weigt and h eight: findings from the NHANES & NHIS 2001-2006. BMC Public Health 9:421PubMedCentralCrossRefPubMed Stommel M, Schoenborn CA (2009) Accuracy and usefulness of BMI measures based on self-reported weigt and h eight: findings from the NHANES & NHIS 2001-2006. BMC Public Health 9:421PubMedCentralCrossRefPubMed
48.
Zurück zum Zitat Bove RM, Brick DJ, Healy BC, Mancuso SM, Gerweck AV, Bredella MA, Sherman JC, Miller KK (2013) Metabolic and endocrine correlates of cognitive function in healthy young women. Obesity 21:1343–1349PubMedCentralCrossRefPubMed Bove RM, Brick DJ, Healy BC, Mancuso SM, Gerweck AV, Bredella MA, Sherman JC, Miller KK (2013) Metabolic and endocrine correlates of cognitive function in healthy young women. Obesity 21:1343–1349PubMedCentralCrossRefPubMed
Metadaten
Titel
Potential factors associated with perceived cognitive impairment in breast cancer survivors
verfasst von
Jamie S. Myers
Jo A. Wick
Jennifer Klemp
Publikationsdatum
01.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2708-7

Weitere Artikel der Ausgabe 11/2015

Supportive Care in Cancer 11/2015 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.